Clinical Trial Update: Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating aSPIrin versus aspirin plus low-dose rivaroxaban for carotid atherosclerotic plaque inflammation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Carotid Artery Stenosis
• Coronary Artery Disease
• Peripheral Arterial Disease

Drugs mentioned

• Aspirin (Aspirin)
• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Asan Medical Center | Conditions: Atherosclerosis of Artery, Coronary Artery Disease | Phase 4 | Status: COMPLETED